
Sunday, October 18, 2020 8:55:24 AM
3 great presentations by the CEO at various investor events over the last month. Partnership with ABBV for Endometriosis testing ($1.2B-$4B market) along with OVA1 tests back at pre-Covid levels, more insurers coming on board like Anthem who controls 21 BC/BS throughout the US.
Making great strides on replacing CA-125 with OVA1 as the SOC which would result in $1B in annual sales.
By 2023 you could be looking at a multi-billion annual revenue stream for AWH.
10 million shares short and float is very small as most shares tied up with insiders and other investors who aren't selling. Going to be a fun run into year end and then the smoke show begins in 2021.
New 52 week highs coming around the corner.
Recent AWHL News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 08:05:42 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/09/2025 08:06:08 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/07/2025 08:05:46 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2025 11:19:40 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM